| Stefan Iorga, MD | |
|
2020 Arlington St Ste 2, Ada, OK 74820-2822 | |
| (580) 436-1506 | |
| (580) 436-1519 |
| Full Name | Stefan Iorga |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 2020 Arlington St Ste 2, Ada, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023095551 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 24300 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stefan Iorga, MD 2020 Arlington St Ste 2, Ada, OK 74820-2822 Ph: (580) 436-1506 | Stefan Iorga, MD 2020 Arlington St Ste 2, Ada, OK 74820-2822 Ph: (580) 436-1506 |
News Archive
Caraco Pharmaceutical Laboratories, Ltd. announced that, as part of the previously announced settlement of the legal proceedings related to Lexapro (escitalopram oxalate) tablets, it closed an Asset Purchase Agreement ("APA") transaction with Forest Laboratories, Inc. ("Forest") to acquire several products from Forest's Inwood line of business.
Cross Country Healthcare, Inc. today announced the refinancing of its revolving loan credit facility and extension of the maturity date by approximately three years. The Company also elected to reduce the aggregate principal amount of the revolving credit facility to $50.0 million. The revolving credit facility was undrawn upon the closing of the refinancing.
Northwest Biotherapeutics (NASDAQ: NWBO)(NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that it has received a decision from the German regulatory agency (the Paul Ehrlich Institute, or PEI) under which the Company's Phase III clinical trial will be able to proceed in Germany after the Company makes three modifications, none of which affect the body of the trial or the bases for seeking product approval.
Thirty-two years ago today, the world's first baby was born after in vitro fertilisation. However, the work that led to the birth of Louise Brown on 25 July 1978 had to be privately funded after the UK's Medical Research Council decided in 1971 against providing the Cambridge physiologist Robert Edwards and the Oldham gynaecologist Patrick Steptoe with long-term financial support. Today, an intriguing paper published in Europe's leading reproductive medicine journal Human Reproduction reveals for the first time the reasoning behind the MRC's much-criticised decision.
› Verified 5 days ago
Benjamin Martin, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1921 Stonecipher Blvd, Ada, OK 74820 Phone: 580-421-4570 Fax: 580-421-6283 | |
Abiodun Fatima Balogun, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1921 Stonecipher Blvd, Ada, OK 74820 Phone: 580-436-3980 Fax: 580-421-6283 | |
Ronald D Bullard, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1921 Stonecipher Dr, Ada, OK 74820 Phone: 580-436-3980 | |
Jennie Mathew, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1921 Stonecipher Dr, Ada, OK 74820 Phone: 580-436-3980 Fax: 580-421-6283 | |
Dr. Stephanie Johniece Schofield, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1921 Stonecipher Dr, Ada, OK 74820 Phone: 580-436-3980 | |
Rachel Renee Birchfield, PA-C Pediatrics Medicare: Medicare Enrolled Practice Location: 1921 Stonecipher Dr, Ada, OK 74820 Phone: 580-421-4550 |